SUBJECTS : Immunology | Immune System | Immune-based Therap
LATEST MANUSCRIPTS IN ImmunoTargets and Therapy
- Xueping Wang, Zhixing Guo, Xingping Wu, Da Chen, Fang Wang, Lewei Yang, Min Luo, Shaocong Wu, Chuan Yang, Lamei Huang, Liwu Fu. Predictive Nomogram for Hyperprogressive Disease During Anti-PD-1/PD-L1 Treatment in Patients with Advanced Non-Small Cell Lung Cancer. ImmunoTargets and therapy. 2023, 12: 1-16
Cited : 2Read More - Azzam A Maghazachi. Globoid Cell Leukodystrophy (Krabbe Disease): An Update. ImmunoTargets and therapy. 2023, 12: 105-111Cited : 2Read More
- Junfeng Zhao, Shaoyu Hao, Ying Li, Xiaoman Liu, Zhaoxuan Liu, Chunhui Zheng, Dan Han. Comparative Efficacy and Safety of Neoadjuvant Immunotherapy with Chemotherapy versus Chemotherapy Alone in Non-Small Cell Lung Cancer: A Propensity Score and Inverse Probability Treatment Weighting Analysis. ImmunoTargets and therapy. 2023, 12: 113-133Cited : 4Read More
- Jiqian Jiang, Yan Wang, Dan Liu, Xiaoyu Wang, Yingqiao Zhu, Juan Tong, Erling Chen, Lei Xue, Na Zhao, Tingting Liang, Changcheng Zheng. Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes. ImmunoTargets and therapy. 2023, 12: 135-147Cited : 0Read More
- Xue-Qian Cai, Qian Huang, Tian-Ping Zhang. The Methylation in and Genes are Associated with the Risk of Pulmonary Tuberculosis. ImmunoTargets and therapy. 2023, 12: 149-163Cited : 1Read More
- Qingyuan Huang, Hang Cao, Qianlan Yao, Xiaoyan Zhou, Hang Li, Qianming Bai, Hong Hu. Mutations Predict Superior Outcomes of Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. ImmunoTargets and therapy. 2023, 12: 165-173Cited : 1Read More
- Jiangpeng Zhu, Guangyao Li, Zhengjun Zhang, Yandong Wang. A Case of Complete Remission in Proficient Mismatch Repair (pMMR) Advanced Colon Cancer Treated with Sintilimab and XELOX. ImmunoTargets and therapy. 2023, 12: 17-23Cited : 0Read More
- Teresa Semalulu, Achieng Tago, Kevin Zhao, Konstantinos Tselios. Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician. ImmunoTargets and therapy. 2023, 12: 175-186Cited : 0Read More
- Chrong-Reen Wang, Wei-Chieh Lin, Tak-Wah Wong. Extended-Release Tofacitinib Therapy for a MDA5 Antibody-Positive Amyopathic Dermatomyositis Patient with Early-Stage Interstitial Lung Disease. ImmunoTargets and therapy. 2023, 12: 187-192Cited : 2Read More
- Sruthi S Nair, Saiju Jacob. Novel Immunotherapies for Myasthenia Gravis. ImmunoTargets and therapy. 2023, 12: 25-45Cited : 26Read More
- Najwa A Mhmoud. Association of Toll-like Receptors 1, 2, 4, 6, 8, 9 and 10 Genes Polymorphisms and Susceptibility to Pulmonary Tuberculosis in Sudanese Patients. ImmunoTargets and therapy. 2023, 12: 47-75Cited : 7Read More
- Simmi Wiggins, Noah A Levit. Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter]. ImmunoTargets and therapy. 2023, 12: 77-78Cited : 0Read More
- Chiara Alfia Ferrara, Gaetano La Rocca, Giuseppe Ielo, Alessandro Libra, Gianluca Sambataro. Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives. ImmunoTargets and therapy. 2023, 12: 79-89Cited : 3Read More
- Khalid Siddiqui, Shaik Sarfaraz Nawaz. Exploration of Immune Targets for Type 1 Diabetes and Latent Autoimmune Disease Immunotherapy. ImmunoTargets and therapy. 2023, 12: 91-103Cited : 2Read More
- Adam Yuh Lin, Joseph Michael Schnitter, Leo I Gordon. Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma. ImmunoTargets and therapy. 2022, 11: 1-10Cited : 10Read More
